Breast Reconstruction Market Growing at a CAGR of 7.0% – Leading Players and Global Forecast

PUNE, India, 2021-Oct-04 — /EPR Network/ — According to the new market research report “Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) – Global Forecast to 2025″, published by MarketsandMarkets™, the global Breast Implant Market size is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0% from 2020 to 2025.

Market Size Estimation;

Both top-down and bottom-up approaches were used to estimate and validate the total size of the breast reconstruction market. These methods were also used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

– The key players in the industry and markets have been identified through extensive secondary research.

– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.

– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593

North America was the largest regional segment of the breast reconstruction market in 2019.

By region, the Breast Implant Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. This is attributed to factors such as the rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products

The prominent players operating in the global breast reconstruction market are Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (Costa Rica), and Silimed (Brazil).

Johnson and Johnson (US) is the dominant player in the breast reconstruction market. The company has a strong portfolio of breast reconstruction products. It has established a significant footprint in Europe, Asia, and Latin, South, & North America. It focuses on organic and inorganic strategies such as product launches. The company operates in this market through Mentor, which it acquired in January 2009. J&J has a strong presence in over 60 countries and a wide network of subsidiaries across the globe. It recently launched a new warranty program for all MENTOR breast implants sold in the US.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593

Breast implants accounted for the largest share of the breast reconstruction market.

Based on the product, segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2019.

The immediate procedures segment accounted for the largest market share in 2019.

Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2019. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.

The unilateral segment accounted for the largest market share in 2019.

Based on type, the breast reconstruction market is segmented into unilateral and bilateral. The unilateral segment accounted for the largest market share in 2019. The increasing incidence of breast cancer and rising awareness are major factors responsible for the dominant share of this segment.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=186501593